Normal view MARC view ISBD view

Overactive Bladder. [Review]

MedStar author(s):

Citation: Obstetrics & Gynecology Clinics of North America. 43(1):59-68, 2016 Mar.PMID: 26880508Institution: MedStar Washington Hospital CenterDepartment: Obstetrics and Gynecology/Female Pelvic Medicine and Reconstructive SurgeryForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Urinary Bladder, Overactive/th [Therapy] | Botulinum Toxins, Type A/tu [Therapeutic Use] | Cholinergic Antagonists/tu [Therapeutic Use] | Electric Stimulation Therapy | Female | Humans | Neuromuscular Agents/tu [Therapeutic Use] | Physical Therapy Modalities | Urinary Bladder, Overactive/di [Diagnosis] | Urinary Bladder, Overactive/et [Etiology]Year: 2016 Local holdings: Available online from MWHC library: 1996 - presentISSN:

0889-8545

Name of journal: Obstetrics and gynecology clinics of North AmericaAbstract: Overactive bladder (OAB) is a condition affecting millions of individuals in the United States. Anticholinergics are the mainstay of treatment. Bladder botulinum toxin injections have shown an improvement in symptoms of OAB equivalent to anticholinergic therapy. Percutaneous tibial nerve stimulation can decrease symptoms of urinary frequency and urge incontinence. Sacral neuromodulation for refractory patients has been approved by the Food and Drug Administration for treatment of OAB, urge incontinence, and urinary retention. Few randomized, head-to-head comparisons of the different available alternatives exist; however, patients now have increasing options to manage their symptoms and improve their quality of life. Copyright © 2016 Elsevier Inc. All rights reserved.All authors: Iglesia CB, White NFiscal year: 2016Digital Object Identifier:

http://dx.doi.org/10.1016/j.ogc.2015.10.002

Date added to catalog: 2017-03-06

Holdings ( 1 )
Title notes ( 3 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article	26880508	Available		26880508

Available online from MWHC library: 1996 - present

Overactive bladder (OAB) is a condition affecting millions of individuals in the United States. Anticholinergics are the mainstay of treatment. Bladder botulinum toxin injections have shown an improvement in symptoms of OAB equivalent to anticholinergic therapy. Percutaneous tibial nerve stimulation can decrease symptoms of urinary frequency and urge incontinence. Sacral neuromodulation for refractory patients has been approved by the Food and Drug Administration for treatment of OAB, urge incontinence, and urinary retention. Few randomized, head-to-head comparisons of the different available alternatives exist; however, patients now have increasing options to manage their symptoms and improve their quality of life. Copyright © 2016 Elsevier Inc. All rights reserved.

English